Metastatic Breast Cancer
Conference Coverage
Uninformed breast cancer patients are making treatment decisions
Clouded by the thought “I have breast cancer,” patients are making uninformed treatment decisions.
From the Journals
Breast cancer test recommended for extended endocrine therapy
The benefit of endocrine therapy after 5 years in early-stage, HR-positive breast cancer is questionable, but the Breast Cancer Index can help...
Diminutio
Dodging potholes from cancer care to hospice transitions
The consequences of suboptimal hospice transitions can damage the mental health and well-being of patient and caregiver.
Conference Coverage
1 in 7 breast cancer patients report worsening personal finances
New survey doesn’t find a link between money woes and stage of disease or treatment.
Conference Coverage
Omega-3 fatty acids linked to less FOXA1 in benign breast tissue
Findings suggest transcription factor could be a helpful biomarker in cancer prevention trials.
From the Journals
MammoRisk: A novel tool for assessing breast cancer risk
The assessment is based on a patient's clinical data and breast density, with or without a polygenic risk score.
Commentary
Breast cancer therapy toxicities: Education and communication
This transcript of a video roundtable, which is available on Medscape.com, has been edited for clarity.
From the Journals
Artificial sweeteners: A modifiable cancer risk?
“Our findings do not support the use of artificial sweeteners as safe alternatives for sugar in foods or beverages,” said the researchers. An...
From the Journals
Few new cancer drugs replace current standards of care
Newer drugs could benefit patients but could increase the cost of care.
Latest News
Ways to lessen toxic effects of chemo in older adults
Three recent high-quality randomized trials evaluated the use of geriatric assessment in older adults with cancer.
Latest News
FDA approves first PARP inhibitor for early
BRCA+ breast cancer